Policy & Regulation
Sensorion welcomes Edwin Moses as board chair
6 July 2020 -

Biotechnology company ALSEN reported on Monday the addition of Edwin Moses as chairman of its board of directors.

Most recently, Dr Moses has served as chairman and CEO of Ablynx over 14 years, leading its rapid growth from a small research-focused organization to one of Europe's most successful biotechnology companies, until its acquisition by Sanofi in 2018.

Previously, Dr Moses worked as the CEO and chairman at Oxford Asymmetry International between 1993-2001.

Currently, Dr Moses is the chairman of Achilles Therapeutics Ltd, Avantium NV and LabGenius Ltd as well as an operating partner at Keensight Capital.

Login
Username:

Password: